New synthetic 3D gel technology for cell culture promises to unlock the potential of ‘mini-organs’ for industrial drug discovery.
20 Dec 2016
Lausanne, Switzerland

Organoids, human mini-organs, are fast becoming a promising tool to bring predictability to drug discovery. In fact, thanks to their resemblance in feature and function to human organs, these miniature 3D in vitro structures grown from patient derived cells can be used to model complex diseases, and can even be used to identify the next generation of targeted drug therapies.

Continue reading…

Back to News and Media